Research programme: dendrimer-based drug conjugates - Genentech/Starpharma
Latest Information Update: 28 Feb 2023
At a glance
- Originator Genentech; Starpharma
- Class Dendrimers; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Unspecified